AstraZeneca

Optimer Said to Draw Takeover Interest From Glaxo, Astellas

Optimer Said to Draw Takeover Interest From Glaxo, Astellas

Bloomberg

AstraZeneca says Pulmicort Respules patent ruled invalid

AstraZeneca says Pulmicort Respules patent ruled invalid

Yahoo/Fly on the Wall

3 Attractive Healthcare Dividend Stocks

3 Attractive Healthcare Dividend Stocks

Motley Fool

Eli Lilly's Livalo: A Big Win For Patients And Investors

Eli Lilly's Livalo: A Big Win For Patients And Investors

Seeking Alpha

Should AstraZeneca and Bristol-Myers Squibb Get Married?

Should AstraZeneca and Bristol-Myers Squibb Get Married?

Motley Fool

How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?

How Much Will FDA Action On Invokana Affect Johnson And Johnson's Revenue And Stock Price?

Seeking Alpha

Is Acadia An Acquisition Target?

Is Acadia An Acquisition Target?

Seeking Alpha

Drug Companies Have Rebounded From The Patent Cliff With Acquisitions Now On The Mind

Drug Companies Have Rebounded From The Patent Cliff With Acquisitions Now On The Mind

Seeking Alpha

Actavis reaches agreement with AstraZeneca to launch generic Crestor in 2016

Actavis reaches agreement with AstraZeneca to launch generic Crestor in 2016

Yahoo/Fly on the Wall